Overview

A Randomized Phase II Study of Concurrent Chemoradiation With Every 3 Week of Cisplatin vs With Weekly Cisplatin in Locally Advanced Nasopharyngeal Carcinoma

Status:
Unknown status

Trial end date:
2014-06-01

Target enrollment:

Participant gender:

Summary

The study try to show the weekly cisplatin based CCRT is not inferior to 3-weekly cisplabe based CCRT in terms of 3-yr progression free survival rate in advanced nasopharyngeal carcinoma

Phase:

Phase 2

Details

Lead Sponsor:

Samsung Medical Center

Treatments:

Cisplatin